Search research articles
Contact Us
Filters
Showing results (71-80 of 616) with videos related to
Page
of 62
Sort By:
Tzu Chi Medical Journal
|
November 3, 2025
Hepatitis C virus and cardiovascular disease: Current knowledge and unmet needs
Chih-Wen Wang, Jee-Fu Huang, Ming-Lung Yu, et al.
Expert Review of Gastroenterology & Hepatology
|
December 18, 2020
Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa
Ming-Lun Yeh, Jee-Fu Huang, Ming-Lung Yu, et al.
Hepatology (Baltimore, Md.)
|
January 24, 2020
Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter
Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2009
Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL
Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, et al.
Intervirology
|
September 17, 2005
Treatment of chronic hepatitis C in southern Taiwan
Wang-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, et al.
Clinical and Molecular Hepatology
|
April 4, 2025
Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients
Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, et al.
Journal of Viral Hepatitis
|
July 6, 2020
Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues
Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, et al.
Journal of Hepatology
|
December 17, 2009
Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: some issues
Kuan-Ta Wu, Jeng-Fu Yang, Wan-Long Chuang, et al.
Clinical and Molecular Hepatology
|
April 26, 2024
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 23, 2026
Hepatitis C elimination: is it time to redefine the goals?
Yasser Fouad, Ming-Lung Yu, Saeed Hamid, et al.
Page
of 62
Search research articles
Search
Showing results (71-80 of 616) with videos related to
Sort By:
Page
of 62
Tzu Chi Medical Journal
|
November 3, 2025
Hepatitis C virus and cardiovascular disease: Current knowledge and unmet needs
Chih-Wen Wang, Jee-Fu Huang, Ming-Lung Yu, et al.
Expert Review of Gastroenterology & Hepatology
|
December 18, 2020
Hepatitis b infection: progress in identifying patients most likely to respond to peginterferon alfa
Ming-Lun Yeh, Jee-Fu Huang, Ming-Lung Yu, et al.
Hepatology (Baltimore, Md.)
|
January 24, 2020
Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter
Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, et al.
Hepatology (Baltimore, Md.)
|
January 30, 2009
Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL
Chia-Yen Dai, Wan-Long Chuang, Jee-Fu Huang, et al.
Intervirology
|
September 17, 2005
Treatment of chronic hepatitis C in southern Taiwan
Wang-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, et al.
Clinical and Molecular Hepatology
|
April 4, 2025
Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients
Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, et al.
Journal of Viral Hepatitis
|
July 6, 2020
Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues
Chia-Yen Dai, Jee-Fu Huang, Wan-Long Chuang, et al.
Journal of Hepatology
|
December 17, 2009
Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: some issues
Kuan-Ta Wu, Jeng-Fu Yang, Wan-Long Chuang, et al.
Clinical and Molecular Hepatology
|
April 26, 2024
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, et al.
Nature Reviews. Gastroenterology & Hepatology
|
February 23, 2026
Hepatitis C elimination: is it time to redefine the goals?
Yasser Fouad, Ming-Lung Yu, Saeed Hamid, et al.
Page
of 62